Where does Daewoong Pharmaceutical Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Daewoong Pharmaceutical Co., Ltd. ranks #5,928 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Daewoong Pharmaceutical Co., Ltd. hold?

Daewoong Pharmaceutical Co., Ltd. holds 57 US utility patents granted between 2015 and 2025, spanning 18 technology areas.

What is Daewoong Pharmaceutical Co., Ltd.'s Innovation Score?

Daewoong Pharmaceutical Co., Ltd. has an Innovation Score of 39.2 out of 100 (top 39% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Daewoong Pharmaceutical Co., Ltd. focus on?

Daewoong Pharmaceutical Co., Ltd.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 43 patents, ranking #419 of 6,058 assignees active in that subclass. Grants appear in 18 CPC subclasses total.

Is Daewoong Pharmaceutical Co., Ltd.'s patent grant rate increasing or decreasing?

Daewoong Pharmaceutical Co., Ltd.'s recent grant velocity is +12% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Daewoong Pharmaceutical Co., Ltd.'s patents?

Daewoong Pharmaceutical Co., Ltd.'s patents average 11.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Daewoong Pharmaceutical Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Daewoong Pharmaceutical Co., Ltd.

USPTO PatentsView assignee record - 57 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Daewoong ranks #5,928 of 49,997 tracked US assignees by granted-patent volume, with 57 patents across 18 technology areas.

#5,928
of 49,997 US assignees by volume: Top 39%
by Innovation Score (39.2/100): 11.4
avg claims per patent: +12%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5928 · Foreign Corporation #5,928 · 57 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 57 grants
UPPER-Q #5,928/49,997
PHOTO-FINISH Clearfield
CPC-FOCUS A61P · 18 areas
INNOV-THIN 39.2/100
CLAIMS-PAR 11.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +12% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Clearfield, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Daewoong’s 39.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.0 pts (36%) Velocity 3.3 pts (8%) Breadth 15.0 pts (38%) Claim depth 6.8 pts (17%)

Qualcomm Incorporated · highest

85
Daewoong Pharmaceuti… · this assignee

39
EcoFasten Solar · near

39
Group Dekko · near

39
IMDB COM · near

39
Wenger Manufacturing · near

39
3D Lighting… · lowest

7

What this shows Daewoong's Innovation Score is 39.2/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Daewoong?

Each dot is one of Daewoong’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Daewoong’s own 11.4 claims/patent is ABOVE the 10.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Daewoong vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Daewoong's grants concentrate

Daewoong Pharmaceutical Co., Ltd. is a focused PatentsView assignee: 18 CPC subclasses with 75.4% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (14 grants) versus a trough of 3 in 2023. By volume, Daewoong sits between Clearfield, Inc. and Doosan Corporation.

Daewoong's three-year grant acceleration

From 2019–2021 to 2022–2024, Daewoong Pharmaceutical Co., Ltd. moved from 22 to 11 grants (0.50x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Clearfield

57
Computational Sys…

57
Cornelius

57
D B Industries

57
Daikin Europe

57
Deliflor Royaltie…

57
Dinkle Electric M…

57
Doosan

57
Daewoong Pharmace… ◀

57

What this shows Daewoong holds 57 patents at rank #5,928, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Daewoong

By rank, the assignees closest to #5,928 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Daewoong's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Daewoong, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Daewoong ranks #419 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Group Dekko, Inc. 39 IMDB.COM, Inc. 39 Wenger Manufacturing Inc. 39 EcoFasten Solar, LLC 39

Similar claim depth

Nearest assignees by average claims per patent (11.4 here).

Qingdao Haier Joint Stock Co., Ltd. 11.4 avg Olympus Medical Systems Corporation 11.4 avg Korea Institute OF Machinery & Materials 11.4 avg Pegatron Corporation 11.4 avg

Daewoong's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Daewoong Pharmaceutical Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	8.8%
2016	5	8.8%
2017	5	8.8%
2018	7	12.3%
2019	4	7.0%
2020	4	7.0%
2021	14	24.6%
2022	5	8.8%
2023	3	5.3%
2024	3	5.3%
2025partial year	2	3.5%

Which technologies does Daewoong Pharmaceutical Co., Ltd. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 43

C07D - Heterocyclic Compounds 41

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 32

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 9

C07K - Peptides 3

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 3

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 3

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 3

B01D - Separation 2

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

C07C - Acyclic OR Carbocyclic Compounds 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 1

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Daewoong Pharmaceutical Co., Ltd.'s patent record in context - here's where to go next.

Daewoong Pharmaceutical Co., Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 75.4% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #5,928 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Daewoong Pharmaceutical Co., Ltd. against Clearfield, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.